bal target $30, page-56

I agree PTW. BAL has stacked it's team with China experts and is poised to strike once it has CFDA approval. They won't take another six months to start to benefit - the preparation will be in place and the revenue growth will be rapid and large. I still believe that BAL has forecast very conservatively in the recent profit upgrade (rightly so) and downplayed China revenue in Q4. DYOR.